The Canadian Ophthalmological Society (COS) is organizing its annual meeting from June 15 to 18, 2023 at the Quebec City Convention Center.
OphtAI will be present and will present the latest developments of its solution for the diagnosis of retinal diseases using artificial intelligence.
Meet OPHTAI on booth 713!
The OphtAI solution and its different versions
OphtAI is available as an integrated part of retinographs and dedicated software, and in this area the company continues to develop its partnerships (see below).
OphtAI is also available as an online service via the MyOphtai website which continues to evolve. It allows ophthalmologists to directly submit the retinas of their patients and to obtain without delay a detection of the main pathologies: diabetic retinopathy, diabetic macular edema, MLA / Drusen, AMD and Glaucoma.
MyOphtai is available as a monthly subscription for unlimited use. One month free of charge is offered: come to our booth to find out how!
A dozen new pathologies detectable from 2024
The teams are working on extending the detection capabilities of the system, and from next year are expected: nevus, cataract, degenerative myopia, macular hole, epiretinal membrane, central retinal vein occlusions, retinal vein branch occlusions, retinitis pigmentosa, diabetic syndrome and maternal inheritance deafness (MIDD), and finally laser photocoagulation scars.
Our integration partners
Novartis is an OphtAI partner for the new care paths in France.
Our scientific partners
Visit the exhibit website.